Trials / Completed
CompletedNCT06625931
Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 Versus NTCB-P in Patients Who Require Parenteral Nutrition
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Open-labeled, Multi-center, Active-controlled, Parallel-group Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 versus NTCB-P in patients who require parenteral nutrition
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NTCB01-1 | 3 Days infusion |
| DRUG | NTCB-P | 3 Days infusion |
Timeline
- Start date
- 2024-11-14
- Primary completion
- 2025-03-28
- Completion
- 2025-03-28
- First posted
- 2024-10-03
- Last updated
- 2025-05-15
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06625931. Inclusion in this directory is not an endorsement.